Encouraging prospects for immunisation against primary cytomegalovirus infection
- 5 February 2001
- Vol. 19 (11-12) , 1356-1362
- https://doi.org/10.1016/s0264-410x(00)00377-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New AdjuvantThe Journal of Infectious Diseases, 1999
- A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses to a Live Attenuated CMV Vaccine (Towne)The Journal of Infectious Diseases, 1999
- Preclinical evaluation of an ALVAC (canarypox)-human cytomegalovirus glycoprotein B vaccine candidateVaccine, 1995
- Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytesJournal of Medical Virology, 1994
- Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gBJournal of General Virology, 1993
- Mathematical modelling of the immunisation of populationsReviews in Medical Virology, 1992
- Increased rate of cytomegalovirus infection among day care center workersThe Pediatric Infectious Disease Journal, 1990
- Increased Rate of Cytomegalovirus Infection among Parents of Children Attending Day-Care CentersNew England Journal of Medicine, 1986
- A prospective study of primary cytomegalovirus infection during pregnancy: final reportBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Strategy for Rubella VaccinationInternational Journal of Epidemiology, 1980